Geulah Livshits
Stock Analyst at Chardan Capital
(4.35)
# 366
Out of 5,050 analysts
233
Total ratings
48.03%
Success rate
19.62%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Geulah Livshits
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NTLA Intellia Therapeutics | Maintains: Buy | $48 → $26 | $9.52 | +173.11% | 17 | Nov 7, 2025 | |
| PVLA Palvella Therapeutics | Maintains: Buy | $73 → $110 | $77.83 | +41.33% | 4 | Nov 7, 2025 | |
| IOVA Iovance Biotherapeutics | Maintains: Buy | $20 → $17 | $2.30 | +639.13% | 15 | Nov 6, 2025 | |
| LXEO Lexeo Therapeutics | Maintains: Buy | $17 | $8.19 | +107.57% | 12 | Nov 5, 2025 | |
| TSHA Taysha Gene Therapies | Maintains: Buy | $12 | $3.83 | +213.32% | 16 | Nov 5, 2025 | |
| SLDB Solid Biosciences | Maintains: Buy | $15 | $4.06 | +269.46% | 9 | Nov 4, 2025 | |
| KRYS Krystal Biotech | Maintains: Buy | $216 → $220 | $197.93 | +11.15% | 14 | Nov 4, 2025 | |
| RCKT Rocket Pharmaceuticals | Maintains: Buy | $11 | $3.17 | +247.00% | 22 | Oct 14, 2025 | |
| IMRX Immuneering | Maintains: Buy | $13 → $20 | $6.89 | +190.28% | 14 | Sep 26, 2025 | |
| MGX Metagenomi | Maintains: Buy | $12 → $11 | $2.16 | +409.26% | 7 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 | $10.50 | +138.10% | 12 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $10 | $3.81 | +162.47% | 6 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 | $1.95 | +515.38% | 10 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 | $1.28 | +603.13% | 12 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $82 | $55.12 | +48.77% | 15 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $120 | $6.29 | +1,809.31% | 5 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $6 | $0.53 | +1,021.91% | 6 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.47 | - | 10 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $41 | $8.47 | +384.06% | 4 | Aug 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $25 | $9.05 | +176.40% | 2 | Mar 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $2.55 | +370.59% | 4 | Mar 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $191 → $208 | $24.54 | +747.60% | 7 | Jan 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $16 | $0.91 | +1,657.08% | 4 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $90 | $11.21 | +702.85% | 1 | Nov 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $5.5 → $4 | $4.23 | -5.44% | 3 | Nov 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $50 → $30 | $4.32 | +594.44% | 1 | Jul 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $15.24 | +18.11% | 1 | Oct 27, 2020 |
Intellia Therapeutics
Nov 7, 2025
Maintains: Buy
Price Target: $48 → $26
Current: $9.52
Upside: +173.11%
Palvella Therapeutics
Nov 7, 2025
Maintains: Buy
Price Target: $73 → $110
Current: $77.83
Upside: +41.33%
Iovance Biotherapeutics
Nov 6, 2025
Maintains: Buy
Price Target: $20 → $17
Current: $2.30
Upside: +639.13%
Lexeo Therapeutics
Nov 5, 2025
Maintains: Buy
Price Target: $17
Current: $8.19
Upside: +107.57%
Taysha Gene Therapies
Nov 5, 2025
Maintains: Buy
Price Target: $12
Current: $3.83
Upside: +213.32%
Solid Biosciences
Nov 4, 2025
Maintains: Buy
Price Target: $15
Current: $4.06
Upside: +269.46%
Krystal Biotech
Nov 4, 2025
Maintains: Buy
Price Target: $216 → $220
Current: $197.93
Upside: +11.15%
Rocket Pharmaceuticals
Oct 14, 2025
Maintains: Buy
Price Target: $11
Current: $3.17
Upside: +247.00%
Immuneering
Sep 26, 2025
Maintains: Buy
Price Target: $13 → $20
Current: $6.89
Upside: +190.28%
Metagenomi
Aug 15, 2025
Maintains: Buy
Price Target: $12 → $11
Current: $2.16
Upside: +409.26%
Aug 12, 2025
Maintains: Buy
Price Target: $25
Current: $10.50
Upside: +138.10%
Aug 8, 2025
Maintains: Buy
Price Target: $12 → $10
Current: $3.81
Upside: +162.47%
Aug 8, 2025
Maintains: Buy
Price Target: $12
Current: $1.95
Upside: +515.38%
Aug 7, 2025
Maintains: Buy
Price Target: $9
Current: $1.28
Upside: +603.13%
Aug 5, 2025
Maintains: Buy
Price Target: $82
Current: $55.12
Upside: +48.77%
Jun 24, 2025
Maintains: Buy
Price Target: $120
Current: $6.29
Upside: +1,809.31%
May 16, 2025
Maintains: Buy
Price Target: $7 → $6
Current: $0.53
Upside: +1,021.91%
Dec 13, 2024
Downgrades: Neutral
Price Target: n/a
Current: $2.47
Upside: -
Aug 11, 2023
Reiterates: Buy
Price Target: $41
Current: $8.47
Upside: +384.06%
Mar 23, 2023
Maintains: Buy
Price Target: $28 → $25
Current: $9.05
Upside: +176.40%
Mar 22, 2023
Reiterates: Buy
Price Target: $12
Current: $2.55
Upside: +370.59%
Jan 18, 2023
Maintains: Neutral
Price Target: $191 → $208
Current: $24.54
Upside: +747.60%
Nov 15, 2022
Maintains: Buy
Price Target: $15 → $16
Current: $0.91
Upside: +1,657.08%
Nov 3, 2021
Maintains: Buy
Price Target: $100 → $90
Current: $11.21
Upside: +702.85%
Nov 3, 2021
Maintains: Neutral
Price Target: $5.5 → $4
Current: $4.23
Upside: -5.44%
Jul 23, 2021
Maintains: Neutral
Price Target: $50 → $30
Current: $4.32
Upside: +594.44%
Oct 27, 2020
Initiates: Buy
Price Target: $18
Current: $15.24
Upside: +18.11%